CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Revenue:
Revenues	$ 1,146,290	$ 475,598	$ 18,662
Expenses:
Research and development	2,534,508	747,027	113,842
Gain on sale of assets	0	0	(9,016)
General and administrative	298,358	145,290	34,417
Total expenses	2,832,866	892,317	139,243
Loss from operations	(1,686,576)	(416,719)	(120,581)
Other income (expense):
Investment income	1,364	1,014	1,512
Interest expense	(21,127)	(15,145)	(13,612)
Other income (expense)	(8,197)	12,591	(13)
Loss before income tax expense	(1,714,536)	(418,259)	(132,694)
Income tax expense	29,215	0	0
Net loss	$ (1,743,751)	$ (418,259)	$ (132,694)
Earnings per share, basic (USD per share)	$ (23.44)	$ (7.27)	$ (5.51)
Earnings per share, diluted (USD per share)	$ (23.44)	$ (7.27)	$ (5.51)
Weighted average number of shares outstanding, diluted (in shares)	74,400	57,554	24,100
Weighted average number of shares outstanding, basic (in shares)	74,400	57,554	24,100
Grants
Revenue:
Revenues	$ 948,709	$ 453,210	$ 15,937
Royalties and other
Revenue:
Revenues	$ 197,581	$ 22,388	$ 2,725